For semaglutide 2.4mg specifically, NICE technology appraisal guidance (TA875) recommends its use only within specialist weight management services, for a maximum duration of 2 years, and for adults with a BMI of at least 35 kg/m (or at least 30 kg/m with weight-related comorbidities)
"This is particularly concerning given that people with obesity-related comorbidities may reap the greatest benefit from treatment," said Professor Thomsen
Upon injection, GLP-1 signals satiety to your brain, making smaller meals satisfactory
A.AbegazT
In most cases, simple modifications to injection technique or identification of contributing factors will resolve the issue, but thorough evaluation ensures that significant underlying conditions are not missed
If medically approved, youll get your prescribed medication by mail within a week